2026 Summit

Teresa DeLellis, PharmD, BCPS, BCGP, AGSF; Chair and Associate Professor of Pharmacy Practice, Geriatrics; Manchester University College of Health Professions, Nursing, and Pharmacy
Dr. Teresa M. DeLellis, PharmD, BCPS, BCGP, AGSF, is Chair and Associate Professor of Pharmacy Practice at Manchester University and a nationally recognized expert in geriatric pharmacotherapy, pharmacogenomics, and transitions of care. As a Board-Certified Pharmacotherapy Specialist and Board-Certified Geriatric Pharmacist, she has dedicated her career to improving medication safety and care outcomes for older adults across inpatient, outpatient, and emergency department settings. Dr. DeLellis is a Fellow of the American Geriatrics Society and has served in multiple leadership roles for national geriatrics and pharmacy organizations, including the American Geriatrics Society Pharmacy Practice Section and the AACP Geriatrics SIG. Dr. DeLellis’ scholarly work focuses on optimizing geriatric medication use, deprescribing, quality measurement, and the integration of pharmacogenomics into care for complex older adults. She is the lead editor of Applying Pharmacogenomics to Optimize Geriatric Care (Springer Nature, 2026) and has authored over 20 peer‑reviewed publications, textbook chapters, and national guidelines-related contributions. Her research and practice innovations, including geriatric emergency department models, pharmacist-led transitions of care pathways, and deprescribing initiatives, have been recognized with multiple awards, including the AACP Geriatrics SIG Distinguished Scholar Award and several Choosing Wisely® Trailblazer Awards. A sought‑after national speaker and educator, Dr. DeLellis has delivered invited presentations for the American Geriatrics Society, Nurses Improving Care for Health-System Elders (NICHE), and academic and health‑system audiences across the country. Her work emphasizes practical, scalable strategies to enhance decision‑making, reduce medication-related harm, and promote person-centered geriatric care. She continues to mentor clinicians, students, and interprofessional teams nationwide in advancing high‑quality, evidence-based care for older adults.

Clayton English, PharmD, MS, BCPP, BCGP, FAAPP; Assistant Professor | University of Washington School of Pharmacy
Dr. Clayton English is an Assistant Professor of Pharmacy at the University of Washington School of Pharmacy, where he practices in the ambulatory care setting as a psychiatric pharmacist at Harborview Mental Health and Addiction Services in Seattle, Washington, and supports the UW Medicine PGY-2 Psychiatry Residency Program. He serves as the assistant director of research in the Center for Pharmacy Practice Transformation which is embedded in the school of pharmacy. The central focus of his research program and position at the UW is to strengthen the sustainable and scalable delivery of pharmacist-provided mental health services by equipping both specialists and generalist pharmacists with the skills and support needed to deliver accessible, safe, and equitable care. He is board-certified in Psychiatric Pharmacy and Geriatric Pharmacy and is an inaugural fellow of the American Association of Psychiatric Pharmacists. From 2010 to 2022, he was a faculty member at Albany College of Pharmacy and Health Sciences and practiced as a clinical pharmacy specialist in psychiatry at the University of Vermont Medical Center. Dr. English’s clinical and research interests focus on psychiatric pharmacy, including mental health services provided by pharmacists, treatment of serious mental illness, and the safety of medications used for psychosis, mood disorders, and adult ADHD. Passionate about interprofessional education and the well-being of students and residents, he actively contributes to professional development through his work with the American Association of Psychiatric Pharmacists (AAPP), including serving as a Senior Editor for the AAPP Psychiatric Pharmacotherapy Review Book and Course and currently serves as the president of the AAPP Foundation. He has been recognized for excellence in teaching and contributions to pharmacy practice, receiving the Award of Excellence in Academic Teaching from the University of Vermont Psychiatry Residency Program in 2012, 2017, and 2019, and being named Vermont Pharmacist of the Year by the Vermont Society of Health-System Pharmacists in 2013. Dr. English completed both his undergraduate and Doctor of Pharmacy degrees at the University of Connecticut. He holds a masters of science degree in health services research from the University of Washington School of Public Health and he completed his post-doctoral residency training in psychiatric pharmacy at Nova Southeastern University.

Lisa Harding, MD 
Dr. Harding is a board-certified psychiatrist and a leading expert in treatment-resistant depression, specializing in advanced interventional psychiatric treatments. As the owner and medical director of Mood Institute, a premier psychiatric intervention practice, she is dedicated to providing innovative mental health solutions tailored to the needs of her patients. Dr. Harding also serves as an expert consultant for Harding Consulting, advising hospitals, medical practices and pharmaceutical companies on effective treatment strategies for individuals suffering from depression. A graduate of Yale School of Medicine, Dr. Harding completed her residency at Yale Psychiatric Hospital, where she was appointed chief resident of interventional psychiatry services. She currently holds the position of assistant clinical professor in the Department of Psychiatry at Yale, where she remains at the forefront of breakthroughs in treatment-resistant depression. Her leadership roles include serving on the board of the American Psychiatric Association (APA) and as vice president of the American Society of Ketamine Physicians, Psychotherapists & Practitioners. Dr. Harding has received numerous accolades for her teaching and mentorship, including the 2024 Irma Bland, MD, Certificate of Excellence in Teaching Residents, and the prestigious Rappeport Fellowship from the American Academy of Psychiatry and the Law. She is actively involved in shaping national psychiatric policy and advocacy, ensuring that the voices of patients and practitioners are heard in the evolving landscape of mental health care.

Mohammad Jafferany, MD, DFAPA, MCPS; Professor, Psychodermatology, Psychiatry & Behavioral Sciences; Covenant HealthCare College of Medicine at Central Michigan University | CMU Medical Education Partner
Dr. Mohammad Jafferany is Professor of Psychodermatology, Psychiatry and Behavioral sciences at Central Michigan University College of Medicine. He has combined training in Dermatology and Psychiatry. He is president of Association for Psychocutaneous Medicine of North America. He has more than 220 scholarly texts and publications to his credit on various topics in psychodermatology in peer reviewed journals. He has edited and authored 12 books on different topics of Psychodermatology such as Pediatric psychodermatology, geriatric psychodermatology, Stress and Skin, Trichotillomania, Essentials of Psychodermatology, Handbook of Psychodermatology, Psychotrichology, and Clinical Psychodermatology, besides contributing chapters on Psychodermatology in various textbooks. Three of his books are translated into Russian, Chinese, and Turkish languages. He has conducted International Psychodermatology workshops and Master Courses in different parts of the world. He is a visiting professor of Psychodermatology in Capital Medical University Beijing, China. He is currently the chairperson of World Psychodermatology Day and was Co-Chair of recently held 1st World Congress of Psychodermatology 2025. He is member of board of directors of internation society of dermatology.

Carol A. Ott, PharmD, MPH, BCPP, FAAP; Clinical Professor of Pharmacy Practice; Purdue University
Carol Ott, PharmD, MPH, BCPP, FAAPP is a clinical professor of pharmacy practice in the Purdue University College of Pharmacy and a clinical pharmacy specialist in psychiatry in the Gender Health program at Eskenazi Health. She is a Clinical Professor of Public Health (Courtesy) in the Department of Public Health at Purdue University and an Adjunct Professor of Psychiatry for the Indiana University School of Medicine. Dr. Ott is a member of the Board of Health for Tippecanoe County and serves as the chair of the Tippecanoe Regional Opioid Settlement Community Committee. In Tippecanoe County, she also sits on the Fetal/Infant Mortality Review Team, Suicide and Overdose Fatality Review Team, and Child Protection Team. She serves Indiana Medicaid as a member of the Drug Utilization Review Board, Mental Health Quality Advisory Committee, Therapeutics Committee, and Psychotropic Medication Advisory Committee. Dr Ott is a clinical consultant psychiatric pharmacist for the Indiana University School of Medicine Department of Psychiatry and Indiana Department of Child Services Psychotropic Review partnership for ward and foster children in Indiana. Statewide, Dr Ott sits on the Indiana Maternal Mortality Review Team. Dr. Ott is the faculty advisor for the AAPP Purdue student chapter and in the College of Pharmacy at Purdue and for the Boiler Substance Awareness Network student organization for Purdue University and the John Martinson Honors College at Purdue. For AAPP, Dr. Ott is an editor for the Psychiatric Pharmacy Review Course.

Aaron Salwan, PharmD, MPH, BCPP; Clinical Pharmacy Specialist, Behavioral Health | Montefiore Nyack Hospital
Dr. Aaron Salwan is a Clinical Pharmacy Specialist in Psychiatry at Montefiore Nyack Hospital, where he also serves as the Founding Director of the PGY2 Psychiatric Pharmacy Residency. A 2017 graduate of the Ohio Northern University Raabe College of Pharmacy, he completed a research fellowship in addiction and behavioral health at East Tennessee State University, earning his Master of Public Health, followed by a specialty residency in neuropsychiatry at Rutgers University. During his MPH training, he completed a 3-month field experience at a syringe service program in Johnson City, TN, where he helped to provide safe injection supplies, naloxone education, and infectious disease testing to individuals with substance use disorders. In his current role, he leads weekly psychoeducational groups for individuals with substance use disorders, where he emphasizes the importance of harm reduction. Dr. Salwan has authored or co-authored more than a dozen publications focused on harm reduction, psychopharmacology, and pharmacist-led mental health services. His research and leadership have advanced pharmacist involvement in behavioral health education and patient-centered psychiatric care. He also holds a faculty appointment as Clinical Assistant Professor in the Department of Psychiatry at East Tennessee State University.

Andrea Winterswyk, PharmD, BCPP; VISN 20 Deputy Pharmacist Executive/Academic Detailing Program Manager; Department of Veterans Affairs
Andrea Winterswyk is the Deputy VISN Pharmacist Executive and Academic Detailing Pharmacy Program Manager for the VISN 20 Pharmacy Benefits Management team within the Veterans Health Administration/Department of Veterans Affairs. She oversees pharmacy services across the VA Northwest Healthcare Network (VISN 20), emphasizing formulary control, evidence-based prescribing, integration of comprehensive medication management by clinical pharmacist practitioners, efficiency in pharmacy operations, and improvement in healthcare quality measures.  Dr. Winterswyk also directs the PGY2 Psychiatric Pharmacy Residency Program at the Boise Veterans Affairs Medical Center and maintains active board certification in Psychiatric Pharmacy (BCPP). Winterswyk's professional education includes a Doctor of Pharmacy from Idaho State University and PGY1 Pharmacy and PGY2 Psychiatric Pharmacy residencies at the Boise VAMC. Her career began with clinical practitioner roles in both mental health and substance use disorders, progressing to leadership and educational positions. She is active on professional committees and advisory boards at VISN and national levels, participating in quality improvement projects to optimize prescribing practices and patient care. Dr. Winterswyk lives in Boise, Idaho with her family.

Kara Wong, PharmD, BCPP, FAAPP; Pain Management, Opioid Safety & PDMP Coordinator; Clinical Pharmacist Practitioner - Pain Management; Minneapolis VA Health Care System
Kara Wong received her Doctor of Pharmacy degree from the University of Wisconsin-Madison School of Pharmacy, and completed her PGY-1 pharmacy practice residency at the Veterans Affairs Puget Sound Health Care System in Seattle, WA as well as her PGY-2 psychiatric pharmacy residency at Center for Behavioral Medicine in Kansas City, MO. She joined the Minneapolis Veterans Affairs Health Care System in 2013 as the inpatient mental health clinical pharmacy specialist and the PGY-2 psychiatric pharmacy residency program director. In 2022, she transitioned to a new role as facility Pain Management, Opioid Safety and Prescription Drug Monitoring Program (PMOP) coordinator. Within the VA she leads numerous quality improvement initiatives relating to safe pain medication and psychotropic use as well as expansion of pharmacy services. For her clinical practice, she is a member of the interdisciplinary primary care pain management team and provides comprehensive medication management under a scope of practice for Veterans with chronic pain. She is also an instructor for Empowered Relief® for chronic pain. Dr. Wong is also actively involved in the American Association of Psychiatric Pharmacists (AAPP) (formerly the College of Psychiatric & Neurologic Pharmacists), and has served on the Business Development Committee (2012-2013), the Publications and Online Products Committee (2013-2014), the Psychiatric Pharmacotherapy Review Course Medication Table Editorial Board (2014) and the BCPP Recertification Editorial Board (2015 – 2026). In recognition of her service AAPP and excellence in advancing the practice of psychiatric pharmacy, she was selected as a Fellow of AAPP in 2025.